| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |